Rezolute (RZLT) EBITDA (2012 - 2026)
Rezolute's (RZLT) quarterly EBITDA came in at -$16.3 million in Q1 2026, up 13.74% year-on-year from -$14.4 million in Q1 2025, and up 28.29% quarter-over-quarter from -$22.8 million in Q4 2025.
Rezolute (RZLT) EBITDA (2012 - 2026) Analysis & Trends
Rezolute has disclosed EBITDA across 15 years of filings, most recently posting -$16.3 million for Q1 2026.
- EBITDA for Q1 2026 came in at -$16.3 million, up 13.74% year-over-year; the trailing twelve-month figure through Mar 2026 was -$81.6 million (down 12.03% YoY), and the FY2025 annual result was -$74.3 million, down 9.02% from the prior year.
- EBITDA came in at -$16.3 million for Q1 2026 at Rezolute, up from -$22.8 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$9.4 million in Q2 2022 to a low of -$24.4 million in Q2 2025.
- The 5-year median for EBITDA is -$15.8 million (2023), against an average of -$16.0 million.
- Across the five-year window, EBITDA sank 104.41% in 2022 and increased 13.74% in 2026, its largest moves.
- Rezolute's EBITDA stood at -$13.6 million in 2022, then fell by 0.86% to -$13.7 million in 2023, then declined by 16.69% to -$16.0 million in 2024, then tumbled by 42.75% to -$22.8 million in 2025, then grew by 28.29% to -$16.3 million in 2026.
- The last three EBITDA figures came in at -$16.3 million (Q1 2026), -$22.8 million (Q4 2025), and -$18.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Rezolute | 520.13 Mn | 520.13 Mn | - | -16.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.33 Mn |
| Dec 31, 2025 | -22.78 Mn |
| Sep 30, 2025 | -18.09 Mn |
| Jun 30, 2025 | -24.44 Mn |
| Mar 31, 2025 | -18.94 Mn |
| Dec 31, 2024 | -15.96 Mn |
| Sep 30, 2024 | -15.01 Mn |
| Jun 30, 2024 | -22.98 Mn |
| Mar 31, 2024 | -17.08 Mn |
| Dec 31, 2023 | -13.67 Mn |
| Sep 30, 2023 | -14.46 Mn |
| Jun 30, 2023 | -12.95 Mn |
| Mar 31, 2023 | -15.80 Mn |
| Dec 31, 2022 | -13.56 Mn |
| Sep 30, 2022 | -9.83 Mn |
| Jun 30, 2022 | -9.42 Mn |
| Mar 31, 2022 | -11.21 Mn |
| Dec 31, 2021 | -12.15 Mn |
| Sep 30, 2021 | -7.64 Mn |
| Jun 30, 2021 | -6.64 Mn |